Bioasis Technologies (CVE:BTI) Shares Cross Below 50-Day Moving Average – Here’s Why

Bioasis Technologies Inc. (CVE:BTI)’s share price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$0.01 and traded as low as C$0.01. Bioasis Technologies shares last traded at C$0.01, with a volume of 5,250 shares trading hands.

Bioasis Technologies Price Performance

The firm has a market cap of C$397,050.00, a PE ratio of -0.12 and a beta of 0.45. The firm has a fifty day simple moving average of C$0.01 and a two-hundred day simple moving average of C$0.01. The company has a debt-to-equity ratio of 27.88, a quick ratio of 0.17 and a current ratio of 0.11.

About Bioasis Technologies

Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007).